Caricamento...

Novel Approaches to Treatment of “Double-Refractory” Multiple Myeloma

Multiple myeloma refractory to both proteasome inhibitors and immunomodulatory agents (IMiDs) has a poor prognosis. With the increasing use of these agents as part of initial therapy, and then in the maintenance setting until disease progression, such drug resistance is an emerging problem of great...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Lee, Hans C., Shah, Jatin J., Orlowski, Robert Z.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2013
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3762449/
https://ncbi.nlm.nih.gov/pubmed/23714530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/EdBook_AM.2013.33.e302
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !